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Abstract
In  this  chapter,  the  modern  uses  of  hydrogels  in  pharmaceutical  and  biomedical
applications are revised following an engineering point of view, i.e. focusing the attention
on material properties and process conditions. The chapter discusses the applications
following the increase in scale‐size. First, the nanoscale systems, i.e. hydrogel nanopar‐
ticles (HNPs), are analysed in terms of preparative approaches (polymerization methods
and uses of preformed polymers) and with a brief mention of the future trends in the field.
Secondly, systems based on hydrogel microparticles (HMPs) are examined following the
same scheme (polymerization methods, uses of preformed polymers, a mention of novel
and future trends). Thirdly, and last but not the least, the hydrogel‐based drug delivery
systems (macroscopic HB‐DDSs) are presented, focusing in particular on tablets made of
hydrogels, discussing the characterization methods and on the modelling approaches
used to describe their behaviour. Other macroscopic systems are also discussed in brief.
Even if the vastness of the field makes its discussion impossible in a single chapter, the
presented material  can be a good starting point to study the uses of hydrogels in
pharmaceutical and biomedical sciences.
Keywords: nano‐hydrogels, micro‐hydrogels, macro‐hydrogels, drug release, model‐
ling
1. Introduction
Hydrogels are hydrophilic polymer networks, which are able to absorb and retain large amounts
of water. Networks can be composed of homopolymers or copolymers, and their network
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
structure and physical integrity are due to the presence of cross‐links of chemical (tie‐points,
junctions) or physical (entanglements, crystallites) nature. Based on the stability/strength of
these cross‐links, hydrogels can either withstand exposure to water or they can degrade and
dissolve in water, after a given exposure time [1]. Because of the wide spectrum of chemical and
mechanical properties as well as their excellent biocompatibility, hydrogels have been exten‐
sively  investigated  for  pharmaceutical  and  biomedical  applications  [2–6].  In  particular,
hydrogels are the main component in controlled drug delivery systems (DDSs), as described in
reviews by Kamath and Park [7], Peppas [8], Peppas et al. [4] and Hoare and Kohane [9]. For
some drugs difficult to be administered, such as the protein, the hydrogels are one of the most
important ways to delivery [10–15]. Hydrogels are also interesting because they can be prepared
in situ [16–20], and their degradation times can be tailored by the used building blocks, the
chemical nature of cross‐links and the cross‐link density [21]. Importantly, because of their high
water content and soft nature, hydrogels are well tolerated by cells and tissues and therefore
they possess a good biocompatibility [22]. Hydrogels are also under investigation in the form
of nanogels as delivery systems for NABDs (nucleic acid‐based drugs, such as pDNA, siRNA
and mRNA) [23,24].
This chapter is intended to give an overview of the hydrogels in pharmaceutical applica‐
tions, with a particular—even if not exclusive—focus on the research activities carried out at
the University of Salerno by Transport Phenomena and Processes Group (http://grup‐
potpp.unisa.it). The chapter is organized following the size of the described systems: first of
all, the applications of nanoscale hydrogels are discussed, then the micro‐scale hydrogels are
analysed and, last but not the least, macroscopic drug delivery systems based on hydrogels
are presented. Of course, since this is a huge topic, the chapter cannot be exhaustive but it has
to be considered as a guiding path to explore the active researches in the field.
2. Nano systems
Over the past few years, hydrogel nanoparticles (HNPs) or nanogels have been investigated
as carrier systems for site‐specific and/or time‐controlled drug delivery. The reason for this
interest is because of the combination of the features of a hydrogel, i.e. hydrophilicity, high
water content and swelling ability, useful for controlled release [25] with those of a nanopar‐
ticle, especially the small size [26]. Both synthetic and natural polymers can be used in hydrogel
nanoparticles production for their different surface properties or bulk erosion rates to control
the release rate of active molecules. The former (synthetic polymers) include especially block
copolymers consisting of two or more segments of simple polymers (blocks) joined in some
arrangement, such as the biodegradable and biocompatible poly(D,L lactic acid) (PLA),
poly(glycolic acid) (PGA) and their copolymer poly(D,L‐lactic‐co‐glycolic acid)
(PLGA)polyvinyl alcohol and polyethylene oxide [27]. The latter (natural polymers) are
characterized by a variety of functional groups, a wide range of molecular weights and variable
chemical composition. Among them, polysaccharides are the more often used: they are
carbohydrate‐based polymers formed of repeating units (monosaccharides) joined together by
glycosidic bonds and can be of algal (alginate), plant (cellulose, starch) and animal (chitosan)
sources [28]. Therefore, hydrogel nanoparticles are ideal drug‐delivery systems due to their
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excellent drug loading capacity, high stability, biologic consistence, flexibility, versatility,
biocompatibility and response to a wide variety of environmental stimuli (such as ionic
strength, pH and temperature) [29]. The techniques for preparing hydrogel nanoparticles can
be divided into two main categories: methods exploiting the direct polymerization of
monomers (based on chemical cross‐links) and methods based on the use of preformed
polymers (based on physical interactions) [30].
2.1. Polymerization methods
The preparation of HNPs via monomer polymerization includes two simultaneous steps,
polymerization and formation of nanostructures, that can be accomplished by interfacial
polymerization, by emulsion polymerization or by controlled radical polymerization [31]. For
example, an inverse emulsion polymerization method was used for poly(ethylene glycol)
(PEG) cross‐linked acrylic nanoparticles for the controlled release of curcumin, a hydropho‐
bic molecule that inhibits proliferation and induces apoptotic cell death in numerous cell lines
established from malignancies such as leukaemia, breast, lung, prostate and colon tumours
[32]. In particular, emulsification was obtained by dispersing the aqueous phase, made of 10%
acrylic acid, 5% sodium hydroxide and 15% water, in a continuous lipophilic phase consist‐
ing of liquid paraffin (68%) and emulsifiers (2%): Span 80 and Tween 80 (75:25 ratio). To the
mixture, first a PEG diacrylate (1%) as cross‐linker and then the initiator, ammonium persul‐
phate, were added. The polymerization was performed at 60°C for 6 h. The obtained parti‐
cles were centrifuged, washed and finally freeze‐dried. Curcumin was loaded in polymer
nanoparticles after polymerization: a nanoparticle/water solution was placed in contact with
a solution of curcumin dissolved in chloroform under constant stirring (by vortex) and
sonication. The curcumin‐loaded nanoparticles were then lyophilized. They showed a higher
entrapment efficiency and lower particle size with the decrease of the cross‐linking degree,
and a release rate dependent on the pH of the releasing medium, in particular, a high swelling
at pH 7.4 than at pH 2.2. However, a higher cross‐linking degree caused a reduction of the
HNPs swelling at pH 7.4, thus a more controlled increase in mesh size that allowed a lower
initial burst release followed by a sustained release. Moreover, curcumin HNPs showed in vitro
a cellular uptake similar to their free counterpart confirming their ability to overcome the
barrier of curcumin's aqueous dispersibility, facilitating the in vivo administration. Again, they
showed more cytotoxicity and apoptotic effects towards cancer cells than free curcumin,
thanks to both nanoparticulate form and the use of hydrophilic polymers for minimizing the
opsonization and prolonging the in vivo circulation of HNPs. A different polymerization
technique was the PRINT (particle replication in non‐wetting templates) particle fabrication
technique, which is characterized by a higher degree of difficulty, but by complete, orthogo‐
nal control over particle characteristics, and an easiness of scaling up [33]. Ma et al. pro‐
posed a PRINT particle fabrication technique for the production of hydrogel nanoparticles
conjugated with siRNA (short interfering RNA, highly used for gene therapy) [34]. The same
technique was used by Kai et al. for the nano‐encapsulation of cisplatin, a cytotoxic drug used
in therapy against a wide variety of cancers [33]. In both cases, a pre‐particle solution was
prepared by dissolving different percentages of reactive monomers in methanol, where the
reactive monomers were: a cure‐site monomer, the oligomeric poly(ethylene glycol) (PEG,
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MM: 700 g/mol) with terminal acryloxy functionality; a hydrophilic monomer, tetraethylene
glycol monoacrylate (HP4A); an amine containing monomer, 2‐aminoethyl methacrylate
hydrochloride (AEM), for providing the amine functionality needed to conjugate PEG onto
the surface of the PRINT particles; a photoinitiator, diphenyl (2,4,6‐trimethylbenzoyl)‐
phosphine oxide (TPO). A thin film was drawn onto polyethylene terephthalate (PET),
laminated to the patterned side of the mould and delaminated at the laminator nip roll. Then
particles were cured by passing the filled mould through a UV‐LED; a polyvinyl alcohol
harvesting sheet was hot laminated to the filled mould and cooled to room temperature and
particles were removed from the mould by splitting the harvesting sheet from the mould.
Particles were then harvested by dissolving the polyvinyl alcohol in water and passed through
a filter. After centrifuge, the cisplatin‐containing particles were also subjected to PEGylation
and succinylation. Incubation of the active molecules for obtaining the conjugation with the
HNPs followed. siRNA‐conjugated HNPs were characterized by a loading efficiency of up
to 29% and high transfection efficiency in vitro by efficiently controlling hydrogel composi‐
tion, surface modification and siRNA loading ratio. For cisplatin HNPs, an inverse correla‐
tion between PEG density (conformation that surface‐bound PEG chains achieve:
‘mushroom conformation', with low density PEG coverage, i.e. PEG chains are not fully
extended away from the nanoparticle surface, and ‘brush conformation’ with the PEG chains
extending away from the nanoparticle surface, resulting in a thick layer ) and drug loading,
and an improved exposure in the blood (higher total amount of drug reaching circulation) and
tumour accumulation (due to both nanodimensions and PEG presence), with concurrent renal
protection were observed.
2.2. Preformed polymers: physical and chemical interactions
Chemically cross‐linked nanogels need the presence of reactive sites along the polymer chains.
Some polymers possess inherent reactive sites, such as polyethyleneimine (PEI) with a high
density of amine functional groups, or natural polymers containing amine or carboxylic acid
groups. Chemical cross‐linking provides nanogels with a great structural stability owing to
irreversible inter‐ or intra‐molecular covalent bonding formations. The chemical networks in
the core inhibit the simple diffusion of hydrophobic drug molecules, giving enhanced
encapsulation efficiency. However, some drawbacks can arise—sometimes the desired
functionality requires complex chemical modifications of cross‐linkers causing the loss of
nanogel versatility; also, small chemicals for the cross‐linking reaction can be toxic for medical
uses [35].
2.3. Novel and future trends
Physically cross‐linked HNPs, usually obtained in aqueous media with mild conditions, can
be modified in size by changing some parameters, such as the pH value, ionic strength and
temperature [29]. In particular, amphiphilic polymers can self‐assemble into micelles with
core–shell structure: the hydrophilic outer shell allows a prolonged circulation, i.e. it is a barrier
against recognition and opsonization, and the hydrophobic core increases the drug loading
via hydrophobic or electrostatic interactions [36]. Physical interactions are of two typologies:
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amphiphilic association, based on Van der Waals links, including hydrogen bond and
hydrophobic interaction, and electrostatic interaction. Used preformed polymers can be
consequently divided into amphiphilic or triblock copolymers that form self‐aggregates in
water by undergoing intra‐ and/or inter‐molecular association between hydrophobic moiet‐
ies due to the minimization of interfacial free energy, and polymers modified with the aim to
have reactive sites to form physical cross‐links via electrostatic interaction [37]. To obtain
physical cross‐linking by self‐association, hydrophobic polymers chains, such as poly(lactic
acid), were grafted on a backbone of dextran in order to obtain water‐soluble biodegradable
graft copolymers of dextrose and PLA able to form nanometric aggregates in an aqueous
solution [38]. The nanogel was prepared by the solvent exchange method: the copolymer was
first dissolved in dimethyl sulphoxide (solvent for both PLA and dextran); then distilled water
was added at a rate of 1 drop every 10 s under high shear stirring until a water content of
about 30–50 wt% was reached; the resulting solution was dialyzed for organic solvent removal,
after that the solution turned slightly opaque because of an aggregate formation with the
hydrophobic PLA cores and the hydrophilic dextran skeleton. The mean diameters of the
aggregates ranged from 16 to 73 nm with narrow size distribution. Moreover, copolymers
showed low critical aggregation concentration values, further decreasing by increasing the
amount of hydrophobic PLA, indicating a strong tendency of the copolymers towards
formation of stable nanogels.
Recent trends in preparation of HNPs exploit the use of a hydrogel core in liposome nanopar‐
ticles to obtain lipogels. Liposomes are vesicular structures consisting of an aqueous core
enclosed in one or more phospholipid layers which possess low intrinsic toxicity and immu‐
nogenicity, capability to incorporate hydrophilic and hydrophobic drugs and good biocom‐
patibility [39]. Wang et al. demonstrated for the first time the possibility to form a poly(acrylic
acid) (PAA) hydrogel core in liposomes for the encapsulation of an anticancer drug 17‐
DMAPG, a geldanamycin (GA) derivative [40]. In particular, a PAA hydrogel core was formed
inside liposomes (already produced by the thin film hydration method) through UV‐initiat‐
ed activation and polymerization of acrylic acid (AA) and N,N'‐methylenebis(acrylamide)
(BA). An optimized pH gradient and electrostatic/hydrophobic interactions between cation‐
ic drug and anionic gel in the liposomal core were used to obtain about 90% of loading
efficiency of the active molecule and its sustained release independently of the external
solution pH, confirming that the lipid bilayer was intact in the presence of the gel core.
Moreover, lipogels did not exert cytotoxicity to cells in vitro neither at the highest concentra‐
tion tested (about 0.4 mg/ml of material).
These few examples showed how polymeric hydrogel nanoparticles are particularly attrac‐
tive, thanks to their easiness of production, affordability and ability of incorporating a variety
of active molecules, including proteins, peptides and oligosaccharides, anti‐tumour agents and
vaccines. However, the development of these systems still require a more comprehensive
characterization, especially about the structure of the HNPs, the application of novel materi‐
als with targeting and environmental sensitivity, the toxicology effect and the interaction with
cells and tissues in vivo, before their full potential can be exploited.




When hydrogels are in the form of macroscopic links confined to micrometric dimensions,
they are termed as microgels or hydrogel microparticles (HMPs), which are different in size
from the sub‐micrometrc HNPs (nanogels) [41]. The size of the particles is a crucial factor in
determining their properties: the specific surface area of a spherical particle, as well as the
diffusion rate, is inversely proportional to the diameter, and the time required for a stimulus
to reach the centre of a gel particle is proportional to the square of the particle's diameter. Thus,
a smaller particle is a much quicker and more serviceable tool; however, if the particles are too
small, they sometimes can cause problems such as difficulty in handling, difficulty in recovery,
unavoidable dissipation and so on. Due to their size and environmentally sensitive nature,
microhydrogels can be used as smart micro‐containers, micro‐reactors, building block for
intelligent materials and for optically functionalized devices [42]. Microgels show unique
advantages in comparison with other polymer systems: in particular, a fast response rate to
external stimuli; suitability for subcutaneous administration; high biocompatibility for the
large amount of water in the swollen state; a large surface area for multivalent bioconjuga‐
tion; an internal network for the incorporation of several active molecules, thus large drug
loading capacities; and adjustable chemical and mechanical properties, and soft architecture
enabling them to flatten onto vascular surfaces, thus simultaneously anchoring in multiple
points [43]. As already seen for HNPs, hydrogel microparticles can be formed from both
natural and synthetic polymers and produced by essentially two methods: particle‐forming
polymerization, including inverse emulsion polymerization and precipitation polymeriza‐
tion, and molecular assembly of existing polymer molecules in aqueous solutions, aided by
the external stimuli, such as temperature, pH and/or the presence of polivalent ions [44]. In
particular, microgels of synthetic polymers are usually obtained starting from a monomer,
such as acrylic acid, methyl methacrylate, acrylamide and ethylene glycol. Some examples are
pH‐sensitive hydrogel P(MAA‐co‐EGMA) microparticles obtained by dispersion photopoly‐
merization by using MAA and ethylene glycol (EG) as monomers [45] and pH‐sensitive
microhydrogels prepared from N‐vinylcaprolactam and methacrylic acid monomers by free
radical polymerization [46]. Instead, biopolymer microgels are obtained either by the poly‐
mer itself, for example, alginate or chitosan that is gelled in a microparticle, or by a macro‐gel,
which is mechanically comminuted for producing anisotropic and irregularly shaped
microgels, of high interest for tissue replacement applications [47], for biosensor, diagnostics
and targeted drug delivery [48]. Methods for producing HMPs are shown in Table 1.
Particle properties which can be manipulated to obtain good entrapment and release
properties are: the degree of crosslinking; particle size and size distribution; polymer type
(controlling their responsiveness to the environment pH, temperature or enzymatic response);
particle surface charge; and particle shape from spherical to elongated rods and fibres. HMPs
can also be designed to shrink or swell by creating an imbalance in the osmotic pressure
between their inside and outside via alteration of pH, temperature or ions in the suspension
[49]. Moreover, existing microhydrogels can be modified to improve their properties or
functions by using post‐treatments such as surface modification, that is, surface grafting or
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surface graft polymerization, and composite formation by inclusion in HMPs of functional
nanoparticles, such as colloidal metals, semiconductor nanocrystals and magnetic
nanoparticles.
Polymerization methods Molecular assembly
Dispersion photopolymerization: It involves the mixing of
monomers with the addition of cross‐linker, UV‐initiator and
dispersion stabilizer followed by ultraviolet light irradiation 
Emulsion technique: Uniform‐sized droplets
(obtained by microfluidics or membrane method) are
dispersed into a continuous phase resulting in oil in
water, water in oil or multiple emulsions. After the
formation of emulsion, the cross‐linking agent is
incorporated to harden the final product. 
Free radical precipiation polymerization: It is a heterogeneous
polymerization that involves a continuous phase in which
monomer and initiator are completely soluble. When the
reaction starts, the yielded polymer remains insoluble and
precipitates. 
Physical gelation: Uniform‐sized droplets (obtained
by atomization by different ways, such as twin nozzle
or ultrasonic atomization) of biopolymer form a
network structure through non‐covalent bonds, such
as hydrogen bonding, electrostatic (ionic) interactions
and hydrophobic interactions, under specific
conditions (for example, temperature or pH). 
Free radical polymerization: It involves a repeated addition of
free radicals building blocks and requires polymer, monomer,
initiator, and cross‐linker. In most cases, the HMPs are obtained
by passing hydrogel through a sieve of desired size, using an
anti‐solvent, or by stirring at a high rate. 
Chemical gelation: Uniform‐sized droplets (obtained
by atomization by different ways, such as twin nozzle
or ultrasonic atomization) of biopolymer form a
network structure via covalent bonds with a chemical
cross‐linking agent. 
Inverse emulsion polymerization: It involves the water in oil
polymerization method: water‐soluble droplets are uniformly
dispersed by mechanical stirring in a continuous organic phase
with the help of oil‐soluble surfactants. Polymerization is
initiated in aqueous droplets upon addition of a radical
initiator. 
Macro‐gelation: It involves the comminution of a
macro‐gel during its gelation in microgel by shearing
the gel to form uniform droplets or, for proteins, by
interrupting the aggregation process of random coil
proteins with shearing or denaturing the protein,
followed by cooling to form a network gel
structure. 
Ionic gelation method: A solution containing the monomer–
cross‐linker and a solution with the polymer and an initiator are
mixed, and the reaction is carried out at a given temperature for
a specific time. 
 
Table 1. Methods for producing HMPs.
3.1. Polymerization methods
As shown in Table 1, the production of HMPs via polymerization can be accomplished by
several methods, that is, photopolymerization, precipitation polymerization, free radical
polymerization, inverse emulsion polymerization and ionic gelation polymerization. Han et
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al. produced hollow‐structured poly(vinyl amine) (PVAm) hydrogel particles, which are able
to encapsulate macromolecules, by using the in situ hydrolysis/cross‐linking reaction on
poly(N‐vinylformamide) (PNVF) particles, previously obtained by using dispersion polymer‐
ization [50]. PNVF particles were produced by performing the polymerization at 70°C for 24
h of a mixture of 19 g of N‐vinyl formamide and 1 g of N,N'‐methylene‐bisacrylamide (MBA)
in 170 g of methanol containing an initiator, 2,2'‐azobis(isobutyronitrile) (AIBN) and a
stabilizer, poly(2‐ethyl‐2‐oxazoline) (PETOZO). After polymerization, all unreacted mono‐
mers and additives were completely removed by repeated centrifugation with an ethanol. The
PNVF particles (about 1 g) were then re‐dispersed in an ethanol solution containing glutaral‐
dehyde, GA (76 ml, conc. GA: 0.1 mol/l). Then, 40 g of a 2 N sodium hydroxide aqueous solution
was slowly added and the reaction was carried out at 80°C for 12 h. After washing away by‐
products, PVAm hydrogel particles were obtained. They were generated by competition
between the partial disconnection of the cross‐linked network in the centre part of PNVF
particles and the secondary cross‐linking induced by additional reaction of glutaraldehyde
with primary amine groups in the PVAm chains located at the periphery of the particles (the
secondary cross‐linking depended on the glutaraldehyde diffusion from the continuous
phase). Particles were characterized by an average diameter of 2.3 μm and showed a dis‐
crete spherical hollow capsule structure. As the cross‐linked hydrogel shell is formed by the
diffusion‐limited secondary cross‐linking, the thickness of the shell was constant at approxi‐
mately 250 nm (the cross‐linking density could be tuned by changing the concentration of
glutaraldehyde). Except the cases using a high amount of glutaraldehyde, all the particles were
found to be non‐toxic to the cells, that is, it is the glutaraldehyde moiety that affects the cell
viability, and not the cationic moieties in PVAm chains. Moreover, regardless of the cross‐
linking density of the hydrogel phase, the HMPs were very adhesive to both the normal human
keratinocyte cells and the normal human dermal fibroblast cells. Thus, the carrier system
seemed to be applicable for macromolecule delivery into the cell.
Thermo‐sensitive microgels useful as drug carriers were produced by precipitation copoly‐
merization of N‐isopropylacrylamide (NIPAM) and N‐hydroxyethylacrylamide (HEAM) with
various concentrations of a cross‐linker in the presence of an anionic surfactant, sodium
dodecylsulphate (SDS) [43]. In particular, the poly(NIPAM‐co‐HEAM) HMPs were synthe‐
sized by free radical precipitation polymerization: a water solution of NIPAM, HEAM, N,N'‐
methylene‐bis‐acrylamide (BIS) and SDS was first heated to 70°C under a gentle stream of
nitrogen, after 1 h a solution of potassium persulphate (KPS) was inserted to start the reaction,
that proceeded for 8 h. After cooling the product to room temperature, the obtained HMPs
were purified by dialysis and then freeze‐dried. The monomer ratio was defined by the
knowledge that the linear copolymer poly(NIPAM‐co‐HEAM) at 10:2 molar ratio in the initial
reaction mixture has a lower critical solution temperature (LCST) close to the physiological
temperature of 37°C. The volume phase transition temperature (VPTT, a characteristic of all
thermoresponsive gels) was evaluated by different methods and it approached very close to
the human body temperature, thus confirming the applicability of these HMPs for biomedi‐
cal and biological applications (requiring a sharp phase transition around the physiological
temperature). In effect, the in vitro release rates of a model drug, propranolol, was strongly
influenced by the temperature: below the VPTT, when HMPs were in a swollen state and no
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steric or hydrophobic interactions occurred, the drug was rapidly released, whereas above the
VPTT, shrunk HMPs produce a reduced release rate.
3.2. Molecular assembly
Self‐assembly methods are characterized by the use of amphiphilic polymers that
spontaneously form self‐aggregates in water (in this way the uses of solvents and harsh
reaction conditions are avoided) by undergoing intra‐ and/or inter‐molecular association
between hydrophobic moieties due to the minimization of interfacial free energy. This process
allow the production of both particles with a shell‐core structure and good stability, depending
on hydrophobic/hydrophilic constituents and polyelectrolytes complexes between two
polymers having different charges, for example, polysaccharides of complementary charge.
Moreover, polyelectrolytes can aggregate into microparticles by cross‐linking with substances
with opposite charge via electrostatic interaction by the ionotropic gelation [30]. For example,
chitosan undergoes ionic gelation due to the complexation with oppositely charged species,
such as tripolyphosphate (TPP). Barba et al. deeply studied the release kinetics and the
influence of the structure of chitosan‐TPP complexed particles on transport phenomena [51].
In particular, vitamin B12‐loaded chitosan microparticles were produced by dripping or
nebulizing via ultrasonic atomization in a water solution of 1% w/w chitosan (containing 0.2%
w/w of B12) in the cross‐linking solution of 1% w/w TPP (with defined reticulation time and
stirring), as shown in Figure 1. Then particles were filtered, washed and finally stabilized by
convective drying at 50°C. The concentration of chitosan was chosen taking into account that
low values brought low encapsulation efficiency and poor particles consistence, instead, at
Figure 1. Sketch of the homemade apparatus assembled and used to produce chitosan and alginate cross‐linked HMPs.
From Barba et al. [51], Copyright © (2012) Croatian Society of Chemical Engineers.
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large values, highly viscous solutions that are difficult to process are obtained. In a similar
manner, the concentration of TPP was chosen, taking into account that chitosan cross‐linked
structure obtained at pH 3 had a higher density (and lower porosity) then those reticulated at
pH 9. The milli‐ and micrometric particles (from dripping and ultrasonic atomization,
respectively) presented an average diameter of 3.75 mm and 613 μm, respectively. High losses
of B12 in the reticulating bulk, giving a low encapsulation efficiency, and a very fast B12 release
rate were observed for both the particles: after 30 min more than of 70% of active molecule was
transferred in the dissolution bulk. These phenomena suggested that diffusion was the
dominant transport phenomenon, thus polymeric network mesh‐size (PNMS) was placed
under investigation. A simple model of the drug release was proposed, considering a drug‐
containing spherical particle inserted in a dissolution medium, to obtain the evolution of the
drug concentration with time, in function of known or estimated parameters, such as number
of particles, particles radius, volume of dissolution medium and initial drug loading
concentration, and of the unknown parameter B12 diffusivity:
( ) 2 0
2
4 1 expO IA Aa D tC t N CV
p td t
é ùæ ö= - -ê úç ÷è øë û (1)
In Eq. (1) the time constant τ is:
( ) 12
1 2
1 14 Da NV Vt p d
-é ùæ ö= +ê úç ÷ç ÷ê úè øë û
(2)
The fitting between experimental data and model data allowed to calculate the B12 diffusivi‐
ty through the polymeric shell resulted in larger milli‐metric particles because the kinetics
(and the extent) of the reticulation may be affected by the size of the produced droplets and
ultrasound can have an effect on gel network. These values were inserted in a relationship
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In this way, they were able to calculate the mesh sizes of two kind of particles (2.3 nm for milli‐
particles and 1.2 nm for microparticles), that were shown to be larger than the B12 Stokes
radius (0.86 nm, estimated by www.chemspider.com); thus, they were able to demonstrate
that the hydrogel structure had to be modified (by physical protocols, for example, by
microwaves curing, or by the use of reactive chemical agents) in order to keep the active
molecule inside.
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The same relationship was already used for estimating the release of a little molecule,
theophylline (TP), from calcium chloride‐cross‐linked alginate HMPs [52]. Production of
particles was performed in the same plant used for chitosan (Figure 1). An alginate/TP aqueous
solution was atomized into a beaker containing 80 ml of a stirred calcium chloride solution
(concentration 8.9 g/l) in order to have a rigid network deriving from the coordination of
alginate molecules by bivalent positive ions. Once reticulated, the alginate particles were
separated by centrifugation or by filtration and dried. Also in this case, the mesh size of
Figure 2. (A) Schematic diagram of the microparticles production. (B) Layout of the microencapsulation single‐pot
semi‐continuous bench scale apparatus (Z‐1, ultrasonic double channel atomizer; D‐3, wet collector; B‐1, microwave
oven cavity; G‐1/G‐2, peristaltic pumps‐core and shell feeding channels; G‐3/G‐4, centrifugal pumps‐reticulation solu‐
tion feeding and suspension recirculation; D‐1/D‐2, core and shell feeding tanks; D‐4/D‐5, reticulation solution tank,
rinsewater tank; and F‐1, filter; box with dashed line: MW cavity). Reprinted with permission from Dalmoro et al. [54],
Copyright © (2014) American Chemical Society.
An Engineering Point of View on the Use of the Hydrogels for Pharmaceutical and Biomedical Applications
http://dx.doi.org/10.5772/64299
211
polymer network was not able to retain the small molecule: from the equation of the release
kinetic by diffusion from a sphere, using the estimated TP diffusivity in sodium alginate
membranes and the particles size (about 100 μm), a 99.9% release of the encapsulated drug
after 2–3 s in a water medium (thus the cross‐linking bulk) was estimated. To improve the
entrapment of a model drug in cross‐linked alginate particles, an external protection could be
the right choice, thus shell‐core particles were produced and compared to matrix (only core)
system. Dalmoro et al. produced both shell‐core and matrix beads of alginate encapsulating
vitamin B12: the shell water solution (alginate 1.5% w/w) and the core water solution
(alginate 1.5% w/w and B12 0.525 g/l and some drops of Tween 80) were separately pumped,
under controlled conditions, into a stainless steel coaxial double‐channel device (a variant of
a typical drop generation systems, such as a syringe used to produce large drops) and dropped
into a stirred water calcium solution (0.89% w/v) to promote alginate chains reticulation. For
matrix particles production, only core channel was fed. After a given time of exposure to
calcium ions, they were filtered, and washed by distilled water. Dissolution tests of B12‐loaded
particles showed that the presence of an additional thin layer of reticulated alginate (the shell‐
core structure) reduced losses during production, giving a loading B12 ratio of about 70% for
shell‐core systems, higher than that of matrix systems, of about 45% (same value theoretically
estimated from the equation of the release by diffusion from a sphere), and allowed a delayed
B12 release [53]. An evolution of shell‐core dripping was the use of a double‐channel ultrasonic
nozzle for the production of shell‐core HMPs. Dalmoro et al. proposed the design of a novel
process to produce microparticles with a shell‐core structure in a bench scale apparatus
purposely realized, involving the coupling of atomization assisted by ultrasonic energy and
microwave heating for stabilization (Figure 2) [54].
Figure 3. Structure of the HMPs produced by ultrasonic‐atomization—two stage polyelectrolyte complexation. From
Dalmoro et al. [59], Copyright © (2016).
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A core feed aqueous solution, composed of 1% active principle, α‐tocopherol, 1.5% alginate
and a mesh size reducer, Tween 80 (as previously described in [53]), together with the shell
feed solution, made of an aqueous solution of 1.5% alginate, were sent to the coaxial ultrason‐
ic atomizer for the nebulization in the CaCl2 cross‐linking aqueous solution. Then they were
filtered and stabilized in the same apparatus and finally recovered. Also in this case, the matrix
system was obtained by atomizing only the core solution, containing the active molecule and
alginate, in the inner channel leaving the external one empty. Both the kinds of HMPs (shell‐
core and matrix) showed an encapsulation efficiency of around 100% and globally good enteric
release properties because α‐tocopherol was negligibly released at simulated stomach pH 1,
and completely released only at intestine simulated pH 6.8. Again, shell‐core HMPs were
preferable to matrix ones, confirming the functional role of the shell structure because they
showed a better gastro‐resistance, that is, a smaller amount of α‐tocopherol released at acidic
pH. Moreover, microwave treatments, used for stabilization, proved to be useful in control‐
led drug release since they caused a little delay in α‐tocopherol release, especially for shell‐
core HMPs. The described production process not only gave alginate HMPs with good drug
release and entrapment properties, but shown several other advantages [55], that is, it was
simple, able to operate at room conditions and in absence of solvents, low energy consump‐
tion, thanks to the use of ultrasound compared to conventional techniques of atomization [56],
with easily predictable and tuneable features (size) of the micro‐droplets as function of process
parameters [56,57]. The process proved to be versatile allowing the encapsulation of a
molecule, ergocalciferol (vitamin D2), which is less lipophilic than α‐tocopherol [58]. The
alginate concentration and flow rates of shell and core solution were kept unchanged. The
variations needed to encapsulate D2 were: vitamin D2 was first dissolved in ethanol and then
emulsified with the aqueous core feeding solution in order to achieve a concentration of 0.2%
(w/v) of D2; Tween 80 in core solution as stabilizer was replaced by Pluronic F127 for its
amphiphilic properties, that is, for its ability to link to alginate with the hydrophilic moiety
and to D2 with the hydrophobic one. Optimization of manufacturing parameters allowed to
obtain high encapsulation efficiency (nearly 92%); good gastro‐resistance properties (less
than 10% release at pH of 1.0, nearly 100% release at pH of 6.8 and 240 min of dissolution);
limited ergocalciferol degradation after 5 months of storage, reduction of D2 degradation
during microwave‐assisted stabilization process compared to the convective one. Another
modification of the process, that is, the coupling of the ultrasonic atomization technique with
the polyelectrolyte complexation, allowed to produce enteric shell‐core HMPs encapsulating
an anionic gastrolesive drug, indomethacin (Figure 3) [59]. Again, both the solutions, core and
shell feed (with unchanged features), were sent to the coaxial ultrasonic atomizer where they
were nebulized and placed in contact with the cross‐linking solution. In this case, the cation‐
ic Eudragit® E 100 (E100) was used as a new complexing agent for the anionic alginate and
also to interact with the anionic drug to raise encapsulation efficiency. However, E100 dissolves
at pH < 5, thus particles obtained after cross‐linking were filtered and put in a solution of the
anionic Eudragit® L30D‐55 (L30D) copolymer that interacted with the cationic E100 and
formed an external gastro‐resistant layer on the fine droplets (fresh shell‐core microparticles).
HMPs were then centrifuged and freeze‐dried. The interaction of the cationic E100 with
alginate first, and then E100 with L30D‐55, obviously caused the formation of larger parti‐
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cles than the previous cases where there was the interaction of alginate with bivalent ions.
Also, HMPs obtained by the double complexation method showed high encapsulation
efficiency (about 74%) and good enteric release properties.
3.3. Novel and future trends
The methods used for HMPs production are numerous and their suitability depends on the
polymer carrier as well as the functionality, particle size and particle size distribution required.
Some methods are accessible at industrial scale, although methods producing HMPs with a
mono‐disperse size distribution are currently best suited to laboratory‐scale manufacturing
only [49]. Moreover, HMPs are sometimes very sensitive to the presence of contaminants, thus
this feature must be improved for enlarging their application field. Therefore, the research
must aim at the development of novel innovative matrices with controlling mechanical
viscoelastic properties, versatile swelling performance, size and internal organization,
triggered degradation behaviour and the enhancement of their biological interactions with
body components. It will be also interesting to explore ‘softness’ for developing biomimetic
particles (i.e. artificial cells), shape changing colloids or particles which evolve or move in time
based on local chemical cues from each other or other entities (e.g. cells). Fundamental will be
also the studies about the mechanisms of passive (traditional methods, i.e. polymerization or
gelation) and driven (innovative methods, such as lithographic processing where hydrogel
colloids are templated in a highly controlled and reproducible manner) self‐assembly in HMPs.
There are also still many opportunities not yet realized in the food industry, such as the
possibility to use them for food preservation (thus, compatibility with foods), satiety control,




Among the compressed systems used in oral administrations, the hydrogel‐based tablets and
matrices are the most diffused and, consequently, studied. The process of drug release from a
hydrogel‐based matrix is very complex and different transport phenomena have to be taken
into account. For these reasons, during the years several experimental techniques and
modelling approaches have been developed to describe the whole release process, starting
from simplified systems (i.e. simple geometry, reduced number of components or 1D mass
transport allowed), to more complex systems (i.e. complex geometry, pharmaceutical forms
composed of several units, each with a specific behaviour).
4.1.1. Experimental approaches
The first step to characterize a hydrogel matrix behaviour is to measure the swelling phenom‐
enon, which can be quantified by water uptake measurement [60], by evaluation of the swelling
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ratio [61] or by rheological analyses [62]. Each of these measurements can be performed using
several experimental techniques, ranging from the simple gravimetric technique to evaluate
the weight gain after a certain dissolution time [60], to a colorimetric technique combined with
the image analysis to identify the position of the swelling, the diffusion and the erosion
fronts [63]. In general, to describe the swelling phenomenon, the use of a combination of
experimental techniques, each with its pros and cons [64], is widely diffused [65] due to the
plurality of the aspects involved.
From an engineering point of view, the experimental measurements that characterize the
hydrogel behaviour inside a compressed pharmaceutical form can be divided into two
groups: (i) the macroscopic measurements, which involve the changes of the whole matrix,
how the entire system evolves during the time; and (ii) the microscopic measurements, which
involve the changes inside the matrix, how a single part of the system is affected by the external
conditions during the time.
Typical examples of macroscopic measurements on a tablet are the evaluation of the total water
uptake of the polymer eroded and the drug released after a certain dissolution time. The water
uptake and the polymer eroded can be easily obtained by a gravimetric technique, which
allows to determine their amounts in the whole matrix during the dissolution time. Concern‐
ing the drug eventually contained into the matrix, using an analytical technique, such as a
spectrometric or a HPLC method, the amount of drug released can be measured and, since the
initial amount of drug in the tablet is usually a known quantity, the drug amount residual into
the matrix can be calculated. Thus, by the use of simple techniques all the macroscopic profiles
can be measured [66].
In order to understand which parameters and phenomena influence the hydrogel behaviour,
a microscopic analysis can be of aid in evaluating what happens inside the polymeric matrix.
As described above, when the water diffuses inside the matrix, the polymer starts to swell,
leading to the formation of a gel layer, which modulates the rate of drug release. For this reason,
evaluate the water distribution inside the matrix is a key topic in the pharmaceutical applica‐
tions and it is the basis of a deeper knowledge of the swelling process, necessary to under‐
stand the tablet behaviour. One of the most used techniques to evaluate the water distribution
inside a polymer matrix (i.e. for a cylindrical tablet along the radius of the matrix) is the image
analysis technique. The basic principle of this method is that, during the hydration of a tablet
inside a dissolution medium, a camera records several grey‐scale pictures of the tablet, which
has a different grey level, depending on the hydration level [67] (i.e. in the glassy white core
of the tablet, where the water has not penetrated, the image remains white, whereas in the
hydrated gel the image is darker). Based on this non‐destructive technique, after a proper
calibration, it is possible to determine the water mass fraction along the radius of a swelling
matrix made of pure hydrogel in which the water uptake is allowed only in the radial
direction [67]. This last hypothesis is fundamental to maintain the water content uniform in a
given section of the matrix. Moreover, with the aid of the image analysis, the movements of
the erosion, swelling and diffusion fronts can be evaluated [68]. The main drawback of this
technique is that if a third component (i.e. a drug) is added to the polymer (and water) in the
tablet, it may interfere with the light intensity and the correlation may fail.
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Focused on the development of a non‐invasive method to study the behaviour of hydrophil‐
ic matrices, a technique based on the nuclear magnetic resonance imaging (NMRI) to pro‐
duce a two‐dimensional map of the density of nuclei inside a complex object has been
developed [69]. This technique is very useful to characterize the water content and the diffusion
phenomena in a swollen hydrogel matrix, and the evolution of the matrix diameter during the
swelling [70]. The extent of the swelling can be identified evaluating the position of the
interface between the dry core of the tablet and the swollen region; the erosion front can be
identified at the interface between the dissolution medium and the swollen region. By the
coupling of a NMR micro‐imaging analysis and of an ad hoc experimental apparatus [71], it is
possible to study the water uptake and the swelling behaviour of extended release tablets of
hydrogels [72]. Once a NMR image has been taken, at each pixel of the image can be associat‐
ed a numerical value that can be put in relation with the proton T2 relaxation (due to the water
protons). Once the proton relaxation has been associated with the amount of water inside the
tablet with a calibration [73], the hydration level of the matrix during the dissolution can be
evaluated both in the axial and in the radial direction, which is a great improvement com‐
pared with the simple image analysis technique.
A laborious but effective technique to determine all the mass fractions inside the matrix is the
gravimetric technique [66], which can be used both for simplified systems, for example, a
cylinder in which the water penetrates only by the radial surface, and in more complex ones,
in which the water uptake is allowed both from radial and axial surface. After a certain
dissolution time, the tablet is withdrawn from the dissolution medium and, using several
punches of different diameters, a series of radial sections and a central core can be obtained.
In each of these sections, measuring the water content (by weighting the hydrated tablet and
drying until constant weight, and weighting once again), the drug content (by dissolving the
section content and assaying the drug concentration in the solution) and the polymer con‐
tent (by difference between the initial weight of the section material and the water and drug
weights), it is possible to obtain the components’ mass fractions. Repeating these evalua‐
tions for several dissolution times, it is possible not only to determine what happens during
the time to the matrix, but even the mass evolution along the radius. These data are particu‐
larly useful to identify the most relevant transport phenomena involved in the dissolution and
to build a predictive tool of the hydrogel‐based matrices behaviour. The described method is
very labour intensive and time consuming, but allows to gain a lot of information about the
matrix behaviour. However, the main drawback of this technique is the fact that it is destruc‐
tive for the samples. A combined approach could be used to compare the image analysis results
with the gravimetric ones [74].
A recent approach to evaluate the degree of hydration of a hydrogel matrix is the use of texture
analysis, which is a non‐destructive method based on indentation or compression tests on the
swollen matrix to evaluate the gel layer position and strength. It is based on the fact that the
resistance of the swollen matrix to the penetration (in the indentation tests) is related to the
water content. Indeed, the higher the water concentration inside the polymer matrix, the larger
the amount of gel formed and the lower the resistance opposed by the matrix. Moreover, due
to the difference between the strength of the glassy core and the gel layer, the position of the
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swelling front and the thickness of the gel layer formed can be easily evaluated during the
swelling by measuring the force opposed to the penetration from the slope of the force‐
displacement diagram. The use of this technique alone does not allow to quantify the water
amount into the matrix, but it gives qualitative indication. For this reason, a method based on
the coupling of the texture analysis and the gravimetric technique has been developed to relate
the water content to the penetration work resulting from an indentation test [75] for a simple
system, in which the water uptake is allowed only by lateral surface. Then, this technique has
been improved to correlate the slope of the force‐displacement diagram to the water amount
even for more complicate system in which the matrix swells both in radial and axial direc‐
tions [76].
4.1.2. Modelling approaches
Once the mechanisms which affect the drug release from a hydrogel‐based compressed system
have been clarified and quantified using both the macro‐ and microscopic approaches, the final
goal of the engineering applied to the study of such pharmaceutical systems is to develop a
mathematical model. This model should be able to describe the observed phenomena and to
predict the matrix behaviour, with the aim to reduce time and costs required by the develop‐
ment of novel dosage forms. During the years, several modelling approaches have been
proposed, starting from the empirical to the mechanistic ones.
First of all, the empirical models have been used to describe the release profile, relating the
fractional drug release from a thin film to the square root of time by Higuchi [77], an ap‐
proach later generalized relating the release to a general nth‐power of time, where ‘n’ is a
function of the drug transport regime [78]: generally, for a thin film, it is 0.5 for Fickian diffusive
process (Higuchi's equation), 1 for the Case‐II transport (swelling‐controlled drug release) and
takes intermediate values for anomalous transport. The hypotheses on which the model was
founded are constant diffusivities and negligible swelling, thus it is not particularly suitable
for hydrogel‐based systems and, despite it is widely used to describe the experimental results,
its use should be avoided to derive phenomenological interpretation.
Then, a more complex modelling approach, which takes into account the simultaneous
presence of the solvent, polymer matrix and drug during the dissolution process, is the
mechanistic approach. To proper describe the complex phenomena which take place during
the dissolution, the mass balance equations, coupled with the momentum conservation
equation, have to be used. Often these models obtain the constitutive equations from the
mixing and elastic free energy of the hydrogel, following the theory of Flory‐Huggins and the
affine network theory, respectively [1]. Being the gel made of cross‐linked polymer and water,
the degree of hydration, which in turns is influenced by the gel elasticity, is crucial to the drug
release purpose [79]. Indeed, the amount of water modifies the stretching of the polymer chains
and tunes the mobility of the active ingredient. Another factor, which affects sensibly the drug
release from such matrices, is the tortuosity of the diffusion path inside the hydrogel [2]. The
tortuosity is an aspect usually difficult to be estimated and it depends on the pore size into the
matrix, on the pore size distribution and it is influenced by the composition and cross‐link
density of the hydrogel polymer network. A recent trend in pharmaceutical application is to
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produce superporous hydrogels, which are characterized by fast swelling and large swelling
ratios [80].
The mechanistic models could be divided into two groups: (i) the multicomponent mixture
models, in which the hydrogel is considered as a single phase constituted by several compo‐
nents; and (ii) the multiphasic models, in which the hydrogel is considered as constituted by
different phases.
The multiphasic models have the advantages of using different phases for the solid (polymer)
and liquid (solvent plus dissolved components) parts, that makes them theoretically easier to
extend to very complex systems such as drug delivery matrices [81]. However, this ap‐
proach has several drawbacks like the high numbers of non‐linear partial differential equa‐
tions (PDEs), that make the system numerically solvable under very limitative conditions, and
the scarce physical meaning of some parameters. Instead, the multicomponent approach, with
more rigorous thermodynamic bases, limits the numbers of PDEs and constrains the varia‐
bles to physical quantities. However, the theoretical complexity, until now, has led to
simplified approaches which take into account only the mass transport equations. One of the
first multicomponent models for drug delivery systems was based on purely diffusive mass
transport equations by Siepmann et al. [82]. Considering the matrix composed by water,
polymer and drug, the water and drug mass transport equations were solved, coupled with
their boundary conditions, in a 2D axisymmetric domain, under several hypotheses: (i) no
volume contraction upon mixing, (ii) fast drug dissolution compared to drug diffusion, (iii)
perfect sink condition for the drug, (iv) strong dependence of the diffusivities (of water and
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where ρi is the mass concentration of the ith species, ρi ,eq is the interface mass concentration of
the ith species and Di the diffusion coefficient of the ith species. R(t) and Z (t) represent the
radius and the thickness, respectively, of the erosion boundaries. The diffusivity has been
described by a Fujita‐type equation [83] and the polymer mass release during the time
(erosion) has been evaluated by the product of an erosion constant and the erosion surface
area, which changes during the time due to the swelling:
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where m2 and m2,0 are the polymer mass and the initial polymer mass, ker is an erosion constant
and Aer is the erosion surface, that is the surface exposed to the external medium. The model
is able to describe the evolution of water, polymer and drug masses during the time for a given
system. Based on this work, a 1D model to describe the hydration of pure HPMC tablet
confined between glass slabs has been developed [67]. The system swelling has been descri‐
bed considering the variation of the total mass due to both the water inlet and the polymer
erosion. The efficacy of this model has been proved by the authors comparing its results and
the experimental data of water mass fraction profiles along the radial direction obtained by
analysing the normalized light intensity of swollen tablet pictures for several dissolution times.
The model has been later improved [84] to describe the drug release kinetics from different
shaped matrices. These models are very useful to describe the behaviour of geometrically
simple systems, but the hypothesis of affine deformation is a big limitation for more com‐
plex systems. For this reason, recently a 2D axisymmetric model was proposed [85] to
overcome the affine deformation hypothesis. In this model, the transport equations for water
and drug have been solved for the respective mass fractions with a finite element method,
along with the proper initial and boundary conditions, and the constitutive equation for the
system density has been obtained considering the summability of the specific volumes of the
single species. The novelty of this model consists in the description of the swelling phenom‐
enon: the inlet water flux has been divided into two components, the first one responsible for
the tablet swelling ( j1,swe) and proportional to a swelling constant (kswe), and the latter respon‐
sible for the inner layer hydration( j1,diff ). The deformation rate of the hydrogel has been defined
by a water mass balance on a boundary element (Aδ), where simultaneously the swelling and
the erosion phenomena (the first leads to a volume increasing and the latter to a volume
decreasing) happen:
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The model has been proved to work in comparison with experimental macroscopic results.
Recently, a mechanistic model based on water diffusion in concentrated systems has been
proposed [86,87]. This model is based on the assumption that: (i) the swelling is due to the
water uptake and to the translocation of polymer, thus the polymer flow at the interface
between the tablet and the external medium causes the swelling and the shape change, without
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polymer release; and (ii) the erosion phenomenon is due to interactions between the tablet
surface and external fluid. Due to this new approach, the model has been found able to describe
not only the macroscopic behaviour of a matrix, but even what happens inside the hydrogel
matrix, and it is in good agreement with the experimental data.
4.2. Hydrogels for biomedical applications
During the years, biomedical applications of the hydrogels in the tissue engineering are
gaining increasing interest, which aims to create biological body parts to replace harvested
tissues and organs. In this application, the polymer plays a major role in the determination of
the cell adhesion, in the formation and growth of a new 3D structured tissue in the human
body; and its selection is governed by the physical, the mass transport properties and the
biological interaction requirements. For these reasons, and due to their properties, the
hydrogels have been explored as systems suitable for tissue engineering [88]. Despite the
critical parameter in the selection of the hydrogel to be used in tissue engineering, the
biocompatibility, the mechanism of gelling [89], the mechanical properties, the controlled
degradation, the interaction with cells [90] and the gel structure are the most important design
parameters to be taken into account [91]. That is, alginate hydrogels, already well exploited
for biomedical applications like wound dressing and drug release, are receiving particular
attention in tissue engineering applications, thanks to the property of forming macro‐porous
anisotropic structure with ordered capillaries [92]. This 3D structure can mimic the primary
microstructural elements of some tissues (nerve, bone, microvasculature, etc.) and facilitate
the cells growth processes. Recently, with a combined experimental and modelling ap‐
proach, the variables that affect the capillaries formation and length, like ion and alginate sol
concentration, have been investigated [93].
A consolidated biomedical application of the hydrogels is the development of patches based
on water swellable polyacrylates for long‐term transdermal drug delivery. One of the most
relevant side effects of a conventional transdermal delivery system is the skin occlusion due
to the long‐term application. In fact, the conventional patches were based on hydrophobic
polymer matrices, and therefore intrinsically occlusive; this drawback can be easily over‐
came with non‐occlusive water swellable matrices as hydrogels. The ability of these poly‐
mers to exchange water with the skin increases their suitability for the transdermal
applications [94]. Of great relevance for the hydrogels used in the development of transder‐
mal patches are the mechanical properties, due to the high mechanical stresses experienced by
these systems. In fact, the force exerted to promote the adhesion on skin surface and the
continuous mechanical stimuli connected with the patient movements are a key parameter to
be taken into account during the development of these delivery systems [95]. Among the
various patches types, the muco‐adhesive buccal patches are largely diffused due to large
permeability of the mucus membranes that allow rapid uptake of a drug into the systemic
circulation. Bio‐adhesion, which is a phenomenon taking place between a biological material
and another, usually a polymer, is the fundamental property in the designing of these
systems [96]. The main factor promoting bio‐adhesion is the presence of carboxyl and hydroxyl
groups on the polymer backbone, to form hydrogen bonds. It was seen that anionic poly‐
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mers form stronger bonds with respect to neutral or cation polymers. Good polymer wetta‐
bility is also required to expose the bond‐forming sites. The polymer molecular weight should
be kept within an optimum range so that the dry system can quickly uptake water (upper limit
for the Mw) to form a gel, that should not be too weak (lower limit for the Mw) [97]. However,
in mucoadhesive applications, although the formation of H‐bonds remains crucial, the
modification of the mucus layer beneath the mucoadhesive material becomes important. This
step, needed to overcome the anti‐adherent properties of mucus, can be attributed to the
macromolecular interpenetration effect or to the dehydration effect [98]. To better under‐
stand the mechanisms that lead to the adhesion phenomenon and to develop a mathemati‐
cal model able to describe the mechanical behaviour and the water uptake of the system,
following the engineering point of view, the adhesion phenomenon has been studied be‐
tween a water‐rich agarose system (which simulates the biological membrane), and a Carbopol
tablet (which simulates the patch) [99].
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